Comparison results
Add for comparison more than one drug or diagnosis.
| Results: Differences General | ✘Autoimmune oophoritis | |||||||||
| Related research | Analogs | |||||||||
| ||||||||||
| Distinctive symptoms | ||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | |||||||||
| Register, to see more distinctive signs of diseases and studies | 83% | |||||||||
| increased ferritin | 78% | |||||||||
| increased alt | 70% | |||||||||
| inflammation of the ovaries | 56% | |||||||||
| primary infertility | 53% | |||||||||
| resistant ovary syndrome | 52% | |||||||||
| infertility female | 49% | |||||||||
| intra-phase infections | 48% | |||||||||
| ovarian dysfunction | 47% | |||||||||
| uterine appendages are increase | 45% | |||||||||
| appendicular-genital syndrome | 45% | |||||||||
| appendages of the uterus | 45% | |||||||||
| menstruation disorder | 44% | |||||||||
| ovarian insufficiency | 44% | |||||||||
| chronic oophoritis | 41% | |||||||||
| female pelvic organs | 41% | |||||||||
| ovarian tumors | 40% | |||||||||
| uterine infertility | 38% | |||||||||
| salpingitis | 36% | |||||||||
| stopped menstruation | 36% | |||||||||
| adnexitis | 36% | |||||||||
| primary and secondary amenorrhea | 36% | |||||||||
| tubal infertility | 35% | |||||||||
| menstruation irregular | 34% | |||||||||
| adhesions in the pelvis | 34% | |||||||||
| inflammation | 34% | |||||||||
| chronic endocervicitis | 33% | |||||||||
| endocrine infertility | 33% | |||||||||
| secondary amenorrhea | 33% | |||||||||
| autoimmune oophoritis | 33% | |||||||||
| secondary infertility | 32% | |||||||||
| ovulatory syndrome | 32% | |||||||||
| drug disease | 32% | |||||||||
| gonorrhea in women | 32% | |||||||||
| oncology | 31% | |||||||||
| trichomoniasis in women | 31% | |||||||||
| neoplasms in small pelvis | 31% | |||||||||
| clamidiosis in women | 31% | |||||||||
| trichomoniasis | 31% | |||||||||
| vulva infections | 30% | |||||||||
| shows genitals | 30% | |||||||||
| vulvovaginitis | 30% | |||||||||
| gonorrheal urethritis | 30% | |||||||||
| progesterone deficiency | 30% | |||||||||
| urogenital clamidiosis | 30% | |||||||||
| necrosis | 30% | |||||||||
| ovarian endometriosis | 29% | |||||||||
| impaired uterine function | 29% | |||||||||
| benign ovarian tumors | 29% | |||||||||
| primary amenorrhea | 28% | |||||||||
| monthly short | 28% | |||||||||
| follicular cyst | 27% | |||||||||
| rare menstruation | 27% | |||||||||
| monthly prolonged | 27% | |||||||||
| ovarian cancer | 26% | |||||||||
| gynecological operations in the anamnesis | 26% | |||||||||
| urethritis | 26% | |||||||||
| endometriosis | 25% | |||||||||
| germinogenic tumors | 25% | |||||||||
| endocervicitis | 25% | |||||||||
| clamidiosis | 25% | |||||||||
| gonorrhea | 25% | |||||||||
| ovarian hypofunction | 25% | |||||||||
| lymphocytosis | 24% | |||||||||
| lack of menstruation | 24% | |||||||||
| endometritis | 24% | |||||||||
| polycystic | 23% | |||||||||
| lower abdominal pain | 23% | |||||||||
| patient's condition | 22% | |||||||||
| uterine tumor | 22% | |||||||||
| cystic fibrosis | 22% | |||||||||
| consequences of taking medications | 22% | |||||||||
| belly enlargement | 21% | |||||||||
| abortions | 21% | |||||||||
| remission | 20% | |||||||||
| heredity predisposition | 20% | |||||||||
| caution | 20% | |||||||||
| consequences of childbirth | 19% | |||||||||
| benign neoplasms | 19% | |||||||||
| presses | 18% | |||||||||
| subacute condition | 18% | |||||||||
| immunodeficiency | 18% | |||||||||
| abdominal pain | 18% | |||||||||
| hormonal disorders | 17% | |||||||||
| surgical infections | 17% | |||||||||
| cancer | 17% | |||||||||
| pregnancy | 17% | |||||||||
| consequences of infection | 16% | |||||||||
| onset of illness | 16% | |||||||||
Instructions
Video 
|
